Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

NCT04485104 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated by the Sponsor due to low patient enrollment.

Conditions

Seizure in Participants With Tuberous Sclerosis Complex
Seizure in Participants With Dravet Syndrome
Seizure in Participants With Lennox-Gastaut Syndrome

Interventions

DRUG: GWP42003-P

Sponsor

Jazz Pharmaceuticals

Collaborators

[object Object]